HIV PrEP Faces Psychological, Financial Obstacles

New York Times: Are We Ready for HIV’s Sexual Revolution?
Donald McNeil, science and health reporter for the New York Times

“The FDA has taken a drug — Truvada — that was approved for HIV treatment in 2004, and approved it for prevention, a use called pre-exposure prophylaxis, or PrEP. On May 14, the Centers for Disease Control and Prevention endorsed PrEP, saying it could benefit up to 500,000 Americans. … Widespread use of the drugs could fight [HIV infections] — but two imposing obstacles loom. … The first is psychological. … The second is financial…” (5/23).